CTMX- Cytomx Therapeutics, Inc.

Over the past 90 days, insiders at Cytomx Therapeutics, Inc. (CTMX) have been net sellers, shedding 1,624 shares worth roughly $5K on balance.

CTMX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	McCarthy Sean A.	987.9K	$3.42M	-
Other	Lester Rachael	650.0K	$2.25M	-
CFO	Ogden Christopher	295.3K	$1.02M	-
Other	Carvajal Alejandra	100.0K	$346.0K	-
Other	Chu Yu-Waye	87.5K	$302.8K	-

Buys and sells only

10 filings · page 13

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Jun 10, 2016	Canaan IX L.P.	Director, 10% Owner	Sell	48,427	$10.07	$487,498.32	-0.4%
Jun 7, 2016	Shannon Timothy M82	Director	Sell	111,498	$10.01	$1,116,289.60	-1.3%
Jun 7, 2016	Canaan IX L.P.	Director, 10% Owner	Sell	111,498	$10.01	$1,116,289.60	-1.3%
Jun 3, 2016	Shannon Timothy M82	Director	Sell	59,621	$10.80	$644,047.71	-0.7%
Jun 3, 2016	Canaan IX L.P.	Director, 10% Owner	Sell	59,621	$10.80	$644,047.71	-0.7%
Jun 1, 2016	Shannon Timothy M82	Director	Sell	22,463	$10.75	$241,477.25	-0.5%
Jun 1, 2016	Canaan IX L.P.	Director, 10% Owner	Sell	22,463	$10.75	$241,477.25	-0.5%
May 27, 2016	Canaan IX L.P.	Director, 10% Owner	Sell	25,082	$10.60	$265,869.20	-0.6%
May 27, 2016	Shannon Timothy M82	Director	Sell	25,082	$10.60	$265,869.20	-0.6%
May 26, 2016	Canaan IX L.P.	Director, 10% Owner	Sell	51,343	$10.34	$530,810.53	-0.6%